The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity

Objective. To evaluate the influence of combined therapy of sitagliptin and metformin on fat metabolism in patients with type 2 diabetes mellitus.Methods. The study included 82 patients (age, 55.3±9.1 years) with obesity and lipid metabolism disorders. None of the patients had reached their target g...

Full description

Bibliographic Details
Main Authors: Aleksander Sergeevich Ametov, Dinara Gadgimagomedovna Gusenbekova
Format: Article
Language:English
Published: Endocrinology Research Centre 2015-10-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/6969